Dr. Steven E. Coutre is a Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. He received his medical degree from the Geisel School of Medicine at Dartmouth and completed his residency at the University of Chicago Medical Center. Dr. Coutre’s research focuses on developing and evaluating new treatments for CLL. He has authored over 200 publications and is actively involved in national committees that establish treatment guidelines. Dr. Coutre is also a dedicated educator, mentoring medical students, residents, and fellows.
Dr. Steven E. Coutre has over 30 years of clinical experience specializing in chronic lymphocytic leukemia (CLL) and other hematologic malignancies. He is recognized for his expertise in novel therapeutic agents, including targeted therapies that have transformed CLL treatment. Dr. Coutre has played a significant role in clinical trials leading to the approval of new drugs, offering patients access to cutting-edge treatments. His patient care philosophy emphasizes personalized medicine and shared decision-making.
Dr. Steven E. Coutre is a Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. He received his medical degree from the Geisel School of Medicine at Dartmouth and completed his residency at the University of Chicago Medical Center. Dr. Coutre’s research focuses on developing and evaluating new treatments for CLL. He has authored over 200 publications and is actively involved in national committees that establish treatment guidelines. Dr. Coutre is also a dedicated educator, mentoring medical students, residents, and fellows.